MSF Delivers Petitions To Pfizer, GlaxoSmithKline Asking For Lower-Cost Pneumonia Vaccines

The Guardian: Shareholders urged to push for cheaper pneumonia drugs
“Shareholders are being urged to use the annual general meetings of Pfizer and GlaxoSmithKline to put pressure on the companies to lower the price of their life-saving pneumonia vaccines…” (Kollewe, 4/27).

Thomson Reuters Foundation: Charity urges price cut for pneumonia vaccine for poor children
“Global charity Médecins Sans Frontières delivered a petition with hundreds of thousands of signatures to pharmaceutical giant Pfizer Inc. on Wednesday, asking the drugmaker to slash the price of its pneumonia vaccine for poor children. Supporters of a proposal to cut the vaccine price to $5 U.S. per needy child took their petition, and a baby’s crib covered with signatures, to the company’s New York City headquarters on the eve of its annual shareholder meeting. They made the same request of GlaxoSmithKline (GSK), which also makes a vaccine to prevent pneumonia…” (Malo, 4/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.